Health Canada Approves TEVIMBRA® (tislelizumab for injection) in Combination with Gemcitabine and Cisplatin for the First-Line Treatment of Adult Patients with Recurr…

BeOne Medicines, a global oncology company, today announced that Health Canada has granted a Notice of Compliance (NOC), ...